HemaSphere
(Aug 2023)
P473: CRISPR/CAS9 GENE EDITING CLARIFIES THE ROLE OF CD33 SNP RS12459419 IN GEMTUZUMAB OZOGAMICIN-MEDIATED CYTOTOXICITY
- Shuki Oya,
- Hidetoshi Ozawa,
- Takayuki Nakamura,
- Yoshimi Maehiro,
- Yusuke Takaki,
- Yoshinobu Fukuyama,
- Yoshitaka Yamasaki,
- Maki Yamaguchi,
- Kazutoshi Aoyama,
- Fumihiko Mouri,
- Koji Nagafuji
Affiliations
- Shuki Oya
- 1 Kurume University, Kurume, Japan
- Hidetoshi Ozawa
- 2 Kurume University, Kurume, Japan
- Takayuki Nakamura
- 2 Kurume University, Kurume, Japan
- Yoshimi Maehiro
- 2 Kurume University, Kurume, Japan
- Yusuke Takaki
- 2 Kurume University, Kurume, Japan
- Yoshinobu Fukuyama
- 2 Kurume University, Kurume, Japan
- Yoshitaka Yamasaki
- 2 Kurume University, Kurume, Japan
- Maki Yamaguchi
- 2 Kurume University, Kurume, Japan
- Kazutoshi Aoyama
- 2 Kurume University, Kurume, Japan
- Fumihiko Mouri
- 2 Kurume University, Kurume, Japan
- Koji Nagafuji
- 2 Kurume University, Kurume, Japan
- DOI
-
https://doi.org/10.1097/01.HS9.0000968800.53072.ea
- Journal volume & issue
-
Vol. 7
p.
e53072ea
WeChat QR code